AbbVie: We are seeking a highly motivated and experienced data scientist to join the Bioinformatics team within the Genomics Research Center (GRC). AbbVie... North Chicago, Illinois

Exact Sciences: Help us change lives At Exact Sciences, we're helping change how the world prevents, detects and guides treatment for cancer. We give patients and... San Diego, California

Exact Sciences: Help us change lives At Exact Sciences, we're helping change how the world prevents, detects and guides treatment for cancer. We give patients and... Cambridge, Massachusetts

George Washington University: I. DEPARTMENT INFORMATION Job Description Summary: Founded in 1824, the GW School of Medicine and Health Sciences (SMHS) is the 11th oldest medical... Washington, Washington DC

Notice NOT-OD-24-081 from the NIH Guide for Grants and Contracts

Notice NOT-NR-24-009 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AT-24-007 from the NIH Guide for Grants and Contracts. The National Center for Complementary and Integrative Health (NCCIH) with the Office of Dietary Supplements (ODS) solicit limited applications for continuation of an established nuclear magnetic resonance (NMR) research resource consisting of raw and meta-data from natural products ranging from crude extracts to purified substances; with the capacity to upload, download, store, search and analyze raw NMR data. The purpose of this limited competition is to promote sustainability, scaling and wider community inclusiveness of the established NMR research resource. This notice of funding opportunity (NOFO) is part of the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. Other components of this Program include the Botanical Dietary Supplements Translational Research Teams (RM1) and Leveraging Big Data to Understand Natural Product Impacts on Whole Person Health (R01).

Notice NOT-MD-24-011 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HD-25-004 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications to participate in a research program cooperative agreement to support theOptimizing Health of Children and Adolescents with Perinatal HIV Exposure Initiative. The objective of this NOFO is to generate information needed to develop and to test interventions for the early detection and reduction of long-term effects of in utero/perinatal exposure toantiretroviral therapy (ART) and/or HIV among individuals who are HIV exposed but uninfected (IHEU).Investigators with innovative thinking and new approaches to address the public health issues facing IHEUs are encouraged to apply.

Notice NOT-AA-24-007 from the NIH Guide for Grants and Contracts

Notice NOT-AA-24-008 from the NIH Guide for Grants and Contracts

Notice NOT-AI-24-026 from the NIH Guide for Grants and Contracts

Notice NOT-AI-24-027 from the NIH Guide for Grants and Contracts

Notice NOT-DK-24-014 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-080 from the NIH Guide for Grants and Contracts

Notice NOT-DA-24-019 from the NIH Guide for Grants and Contracts

Notice NOT-AI-24-024 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-NS-24-016 from the NIH Guide for Grants and Contracts. Reissue: RFA-NS-21-023 - The purpose of this Funding Opportunity Announcement (FOA) is to encourage investigators to pursue translational activities and small clinical studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, obtaining an Investigational Device Exemption (IDE) for a Significant Risk (SR) study, as well as a subsequent small clinical study. The clinical study is expected to provide information about the device function or final design that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. This FOA is a milestone-driven cooperative agreement program and will involve participation of NIH program staff in negotiating the final project plan before award and monitoring of research progress.

Notice NOT-DK-24-017 from the NIH Guide for Grants and Contracts

AbbVie: AbbVie's Ophthalmology Discovery Research group is looking for a highly motivated and experienced ocular scientist with a multidisciplinary backgr... Irvine, California